Brazilian initial experience with lung transplantation due to irreversible lung fibrosis post-COVID-19 in a national reference center
a cohort study
Keywords:
Extracorporeal membrane oxygenation, Lung transplantation, COVID-19Abstract
BACKGROUND: Lung transplantation (LTx) has been discussed as an option for treating irreversible lung fibrosis post-coronavirus disease 2019 (COVID-19), in selected cases. OBJECTIVES: To report on the initial experience and management of end-stage lung disease due to COVID-19 at a national center reference in Brazil. DESIGN AND SETTING: Cohort study conducted at a national reference center for lung transplantation. METHODS: Medical charts were reviewed regarding patients’ demographics and pre-COVID-19 characteristics, post-LTx due to COVID-19. RESULTS: Between March 2020 and September 2021, there were 33 cases of LTx. During this period, we evaluated 11 cases of severe COVID-19-related acute respiratory distress syndrome (ARDS) that were potentially candidates for LTx. Among these, LTx was only indicated for three patients (9.1%). All of these patients were on venovenous extracorporeal membrane oxygenation (ECMO), and the procedure that they underwent was central venoarterial ECMO. All three patients were still alive after the first 30 postoperative days. However, patient #1 and patient #2 subsequently died due to fungal sepsis on the 47th and 52nd postoperative days, respectively. Patient #3 was discharged on the 30th postoperative day. CONCLUSIONS: LTx is feasible among these complex patients. Survival over the first 30 days was 100%, and this favors surgical feasibility. Nonetheless, these were critically ill patients.
Downloads
References
Perondi B, Miethke-Morais A, Montal AC, et al. Setting up hospital care provision to patients with COVID-19: lessons learnt at a 2400-bed academic tertiary center in São Paulo, Brazil. Braz J Infect Dis. 2020;24(6):570-4. PMID: 33157034;https://doi.org/10.1016/j.bjid.2020.09.005.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. PMID: 31986264; https://doi.org/10.1016/S0140-6736(20)30183-5.
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. PMID: 32105632; https://doi.org/10.1016/S2213-2600(20)30079-5. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.
Ranzani OT, Bastos LSL, Gelli JGM, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407-18. PMID: 33460571; https://doi.org/10.1016/S2213-2600(20)30560-9.
Li Bassi G, Suen JY, Dalton HJ, et al. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients. Crit Care. 2021;25(1):199. PMID: 34108029; https://doi.org/10.1186/s13054-021-03518-4.
Ferreira JC, Ho YL, Besen BAMP, et al. Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021;11(1):92. PMID: 34097145; https://doi.org/10.1186/s13613-021-00882-w.
Tonna JE, Abrams D, Brodie D, et al. Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. 2021;67(6):601-10. PMID: 33965970; https://doi.org/10.1097/MAT.0000000000001432.
Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750-2. PMID: 32422177; https://doi.org/10.1016/S2213-2600(20)30222-8.
Chen JY, Qiao K, Liu F, et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. Chin Med J (Engl). 2020;133(12):1390-6. PMID: 32251003; https://doi.org/10.1097/CM9.0000000000000839.
Lang C, Jaksch P, Hoda MA, et al. Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient. Lancet Respir Med. 2020;8(10):1057-60. PMID: 32857987; https://doi.org/10.1016/S2213-2600(20)30361-1.
Bharat A, Machuca TN, Querrey M, et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med. 2021;9(5):487-97. PMID: 33811829; https://doi.org/10.1016/S2213-2600(21)00077-1.
Cypel M, Keshavjee S. When to consider lung transplantation for COVID-19. Lancet Respir Med. 2020;8(10):944-6. PMID: 32857989; https://doi.org/10.1016/S2213-2600(20)30393-3.
Ceulemans LJ, Van Slambrouck J, De Leyn P, et al. Successful doublelung transplantation from a donor previously infected with SARSCoV-2. Lancet Respir Med. 2021;9(3):315-8. PMID: 33275902; https://doi.org/10.1016/S2213-2600(20)30524-5.
Kaul DR, Valesano AL, Petrie JG, et al. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing. Am J Transplant. 2021;21(8):2885-9. PMID: 33565705; https://doi.org/10.1111/ajt.16532.
Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679-81. PMID: 32160451; https://doi.org/10.1056/NEJMp2003539.
Macedo BR, Garcia MVF, Garcia ML, et al. Implementation of Tele-ICU during the COVID-19 pandemic. J Bras Pneumol. 2021;47(2):e20200545. PMID: 33950091; https://doi.org/10.36416/1806-3756/e20200545.
Urlik M, Szułdrzyński K, Stącel T, et al. First lung transplantation as a treatment of a patient supported with extracorporeal membrane oxygenation (ECMO) after COVID-19 in Poland. Adv Respir Med. 2021;89(3):328-33. PMID: 34196386; https://doi.org/10.5603/ARM.a2021.0042.
